EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Eosinophilic Esophagitis as a Complex Th2 Inflammatory Disease: Results of a Prospective Long-Term Study in Children

Sabrina Degen, Theresa Hironimus, Tobias Rechenauer, Christoph Ehrsam, Anja Rabe, Adrian Regensburger, Aline Rückel, Arndt Hartmann, Ralf Rieker, Joachim Woelfle, Anja Rappl, André Hoerning

Digestive Diseases · 07.11.2025 · 44 (1) · 12-24

DOI: 10.1159/000549092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases, online erschienen am 07.11.2025. Verfasst von Sabrina Degen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology and Hepatology, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Al…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Th2 Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

While the eosinophilic esophagitis (EoE) has become the second most common disease entity causing esophageal dysfunction, there is currently a lack of data reporting on pediatric EoE from Germany. This monocentric longitudinal study seeks to fill this gap by investigating treatment success, atopic co-morbidities, and potential blood parameters in a real-world setting.

Methods

This study analyzed data on children with EoE (n = 50), gastroesophageal reflux disease (GERD, n = 13), and controls (n = 5). Evaluated characteristics included clinical manifestations, atopy, and treatment success during disease progress. We defined the primary endpoint as histological remission in all esophageal locations (proximal, mid, distal). Secondary endpoints were histological-clinical, histological-endoscopic, and histological-clinical-endoscopic remission.

Results

Of 50 patients (0.5–16.9 years), 26% (n = 13) responded to proton-pump inhibitors (PPI-R) and 74% (n = 37) needed other forms of treatment (PPI-NR). Atopic co-morbidities were observed in 46% (PPI-NR) and 23% (PPI-R). Primary PPI treatment resulted in histological remission in 13 patients (median: 2 [2;4.5] months); only one (8%) achieved complete endoscopic-clinical-histological remission. Thirty-two PPI-NRs (84%) reached histological remission after a median of 7 [4;11] months, but only eleven (34%) acquired complete histological-clinical-endoscopic remission. Absolute blood eosinophil count (AEC) was increased within active EoE (420 [250;550] cells/µL). It distinguished EoE from controls (cutoff 90 cells/µL, sensitivity/specificity: 95.7%/80%) and from GERD (180 cells/µL, 87.5%/66.7%). Eosinophilic cationic protein (ECP) differed between children with active EoE and controls (10 µg/L, 86.7%/100%).

Conclusions

Patients’ characteristics are comparable to those from other European countries. AEC and ECP were increased in EoE patients. Achieving complete remission required an intensified therapy regime.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisTh2 CellsHumansChildMaleFemaleChild, PreschoolAdolescentProton Pump InhibitorsInfantProspective StudiesGastroesophageal RefluxLongitudinal StudiesTreatment OutcomeInflammation

Stichwörter der Autor:innen

ChildrenEosinophilic cationic proteinEosinophilic esophagitisGastroesophageal reflux diseaseGermany

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology and Hepatology, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Clinic for Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Pediatrics and Adolescent Medicine, Helios Klinikum Erfurt, Erfurt, Germany.
  • Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Institute of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Department of Pediatric Gastroenterology and Hepatology, Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany, andre.hoerni…

Zitieren

APA

Degen, S., Hironimus, T., Rechenauer, T., Ehrsam, C., Rabe, A., Regensburger, A., Rückel, A., Hartmann, A., Rieker, R., Woelfle, J., Rappl, A., & Hoerning, A. (2025). Eosinophilic Esophagitis as a Complex Th2 Inflammatory Disease: Results of a Prospective Long-Term Study in Children. Digestive Diseases, 44(1), 12-24. https://doi.org/10.1159/000549092

Vancouver

Degen S, Hironimus T, Rechenauer T, Ehrsam C, Rabe A, Regensburger A, et al. Eosinophilic Esophagitis as a Complex Th2 Inflammatory Disease: Results of a Prospective Long-Term Study in Children. Digestive Diseases. 2025;44(1):12-24. doi:10.1159/000549092

BibTeX
@article{Degen2025,
  author = {Degen, Sabrina and Hironimus, Theresa and Rechenauer, Tobias and Ehrsam, Christoph and Rabe, Anja and Regensburger, Adrian and Rückel, Aline and Hartmann, Arndt and Rieker, Ralf and Woelfle, Joachim and Rappl, Anja and Hoerning, André},
  title = {Eosinophilic Esophagitis as a Complex Th2 Inflammatory Disease: Results of a Prospective Long-Term Study in Children},
  journal = {Digestive Diseases},
  year = {2025},
  volume = {44},
  number = {1},
  pages = {12--24},
  doi = {10.1159/000549092}
}
Kostenlos starten →